Integrated clinical pharmacy activities into the pediatric kidney graft pathway

Julie Martin1, Élise Jandot2, Valentine Bréant2

  • 1Hospices civils de Lyon, pharmacie, Lyon, France

Nephrologie & Therapeutique
|December 7, 2023
PubMed

Insights

Integrating clinical pharmacy services into pediatric renal transplant care is feasible and beneficial. This approach enhances medication management and patient adherence, improving outcomes in this high-risk population.

Area of Science:

  • Nephrology
  • Pediatric Nephrology
  • Clinical Pharmacy

Background:

  • Pediatric renal graft recipients face risks of care discontinuation, impacting therapeutic adherence.
  • Optimizing medication management is crucial for long-term graft survival and patient well-being.

Purpose of the Study:

  • To evaluate the feasibility and integration of clinical pharmacy services within the pediatric renal graft care pathway.
  • To assess the impact of these services on medication prescription analysis and patient follow-up.

Main Methods:

  • A three-stage feasibility study: structuring, implementation, and evaluation.
  • Inclusion of 32 pediatric patients over 8 months, encompassing pre-transplant, immediate, and remote post-transplant phases.
  • Methods included patient interviews and pharmaceutical analysis of medication prescriptions.

Main Results:

  • All patients in pre-transplant and immediate post-transplant phases benefited from clinical pharmacy activities.
  • Pharmaceutical analysis identified at least one problem in all initial M0 prescriptions.
  • Follow-up maintenance was provided to half of the transplanted patients at Month 1 and one patient at Month 3; no Month 6 follow-up was feasible.

Conclusions:

  • Clinical pharmacy activities are feasible and can be well-integrated into the pediatric renal graft care pathway.
  • The study highlights the importance of pharmaceutical review in identifying and addressing medication-related issues.
  • Further research is needed to optimize long-term follow-up strategies within this integrated care model.

Related Concept Videos

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.4K
Drug Elimination by Renal Route: Glomerular Filtration01:17

Drug Elimination by Renal Route: Glomerular Filtration

The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production takes place. A nephron has two main components: a renal corpuscle and a renal tubule. Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent...
5.7K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
95
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
99
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
192
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
216